Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Parathyroid hormone added to bovine bone graft for upper jaw sinus augmentation

Official title: Radiographical, Histomorphometrical and Biomarker Analysis After Maxillary Sinus Augmentation Utilizing Xenograft Particulate Bone Graft Mixed With Parathyroid Hormone: A Randomized Controlled Study

Run by University of Baghdad · NCT07459075 · Data updated 2026-11-12

This will test whether adding parathyroid hormone to a bovine bone graft helps adults needing maxillary sinus augmentation get stronger bone for dental implants.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Baghdad
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Baghdad)
StatusRecruiting
StartedMay 1, 2025
Main results expectedMay 2026
Study endsNovember 2026
Registry record updatedMarch 9, 2026
Trial IDNCT07459075 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with healed posterior maxillary sites, residual bone height ≤3 mm, adequate ridge width (≥5 mm), good oral hygiene, and no systemic conditions that impair healing.

Probably not a fit

People with residual bone height >3 mm, sinus membrane thickness >5 mm, active maxillary sinusitis, uncontrolled systemic illness, or current use of interfering medications (bisphosphonates, corticosteroids, recent chemo/radiation) are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional Phase 4 protocol enrolls adults needing maxillary sinus augmentation before dental implant placement and compares bovine-derived xenograft alone versus the same graft mixed with parathyroid hormone (PTH 1-34). Participants undergo sinus lift surgery with the assigned graft material and are followed for four months before implant placement. Outcomes include cone beam CT measurement of bone density at planned implant sites, histomorphometric analysis of biopsy samples for trabecular bone and cellular markers, measurement of osteopontin as a biomarker, and assessment of primary implant stability. The trial is conducted at the University of Baghdad and uses radiographic, histological, biomarker and clinical measures to compare bone regeneration and remodeling between groups.

Why it matters

Potential benefit: If successful, the approach could speed or improve bone regeneration in the sinus and increase primary implant stability, reducing the risk of implant failure.

How similar studies have gone: Parathyroid hormone shows bone-building effects in animal studies and limited human bone-healing reports, but clinical evidence specifically for maxillary sinus augmentation is sparse.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

* Healthy individuals without any systemic disease/local pathological lesion at the sinus zone that compromise the bone healing potential.
* Fair to good oral hygiene.
* Patient's age ≥ 18 years.
* The RBH was 3 mm or less. Atrophic edentulous posterior maxillary ridge (missing tooth or teeth in the sinus zone), with adequate ridge width (≥ 5 mm) to accommodate an average DI diameter and to gain primary implant stability.
* Healed planned implant insertion site.

Exclusion criteria

* Medically compromised patients with any of the following conditions that could interfere with normal healing potential or osseointegration such as uncontrolled diabetes mellitus, currently on chemotherapy, corticosteroid or bisphosphonate, radiotherapy of the head and neck in the past 2 years, bleeding disorders, ongoing pregnancy, thyroid hormones problems and psychiatric disorders.
* The RBH ˃ 3 mm.
* Thickness of the SM ˃ 5 mm.
* Maxillary sinusitis (acute and chronic) or any other pathologies in the MS.
* Previous MS surgery.
* Heavy smoking ˃ 20 cigarettes daily and/or alcohol abuse.
* Parafunctional habits such as severe bruxism and clenching.

Where it's running

  • Baghdad University
    Baghdad, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.